Longboard Pharmaceuticals has commenced the Phase III DEEp SEA Study of bexicaserin for treating seizures in Dravet syndrome ...
ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...
An NHS paediatrician sent a WhatsApp message offering children and parents £1,500 to take part in Moderna’s Phase III ...
AbbVie has revealed positive data from a post-hoc analysis of Phase III trials of RINVOQ in treating atopic dermatitis (AD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback